YIH
GMED icon

Y-Intercept (HK)’s Globus Medical GMED Stock Holding History

Y-Intercept (HK)’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,764
Closed -$1.96M – 1888
2026
Q1 		$1.96M Buy
+22,764
New +$2.04M 0.04% 720
2025
Q4 		– Sell
-61,455
Closed -$3.52M – 1710
2025
Q3 		$3.52M Sell
61,455
-75,055
-55% -$4.32M 0.08% 337
2025
Q2 		$8.06M Buy
136,510
+120,909
+775% +$7.81M 0.2% 111
2025
Q1 		$1.14M Buy
15,601
+5,041
+48% +$417K 0.08% 359
2024
Q4 		$873K Sell
10,560
-9,316
-47% -$735K 0.06% 480
2024
Q3 		$1.42M Buy
19,876
+8,366
+73% +$591K 0.09% 303
2024
Q2 		$788K Sell
11,510
-3,991
-26% -$238K 0.04% 602
2024
Q1 		$831K Buy
+15,501
New +$833K 0.06% 462
2023
Q3 		– Sell
-3,925
Closed -$234K – 1241
2023
Q2 		$234K Buy
+3,925
New +$224K 0.02% 868
2022
Q3 		– Sell
-13,917
Closed -$781K – 1086
2022
Q2 		$781K Buy
+13,917
New +$915K 0.1% 287

Other funds holding GMED

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
CF
Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return
AHIA
Andrew Hill Investment Advisors Naples, Florida $135M AUM 50.1% 1-Year Est. Return

Y-Intercept (HK)'s GMED Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 22,764 shares — an estimated $1.96M sold.

Y-Intercept (HK) first reported a position in GMED in Q2 2022 and held it in 10 quarters. The position peaked at $8.06M in Q2 2025. 62 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Y-Intercept (HK) reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 22,764 Globus Medical shares in Q2 2026, an estimated $1.96M.
  • Y-Intercept (HK) first reported a position in Globus Medical in Q2 2022 and held it in 10 quarters.
  • Y-Intercept (HK)'s Globus Medical position peaked at $8.06M in Q2 2025.
  • 62 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.